Cargando…
Angioedema, ACE inhibitor and COVID-19
SARS-CoV-2, the virus responsible for COVID-19, binds to the ACE2 receptors. ACE2 is thought to counterbalance ACE in the renin-angiotensin system. While presently it is advised that patients should continue to use ACE inhibitors or angiotensin receptor blockers, questions still remain as to whether...
Autores principales: | Grewal, Ekjot, Sutarjono, Bayu, Mohammed, Ibbad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7482445/ https://www.ncbi.nlm.nih.gov/pubmed/32912894 http://dx.doi.org/10.1136/bcr-2020-237888 |
Ejemplares similares
-
Acute transverse myelitis in COVID-19 infection
por: Chow, Chian Chiang Nicholas, et al.
Publicado: (2020) -
Coronavirus disease-19 (COVID-19) associated with acute necrotising pancreatitis (ANP)
por: Kumaran, Naren K, et al.
Publicado: (2020) -
Non-convulsive status epilepticus: COVID-19 or clozapine induced?
por: Sokolov, Elisaveta, et al.
Publicado: (2020) -
Cytokine storm and use of anakinra in a patient with COVID-19
por: Nemchand, Priyanka, et al.
Publicado: (2020) -
Rhabdomyolysis and acute kidney injury in severe COVID-19 infection
por: Taxbro, Knut, et al.
Publicado: (2020)